These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 17652336
1. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Chen LH, Jiang CC, Kiejda KA, Wang YF, Thorne RF, Zhang XD, Hersey P. Carcinogenesis; 2007 Nov; 28(11):2328-36. PubMed ID: 17652336 [Abstract] [Full Text] [Related]
2. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P. Cancer Res; 2007 Jun 15; 67(12):5880-8. PubMed ID: 17575157 [Abstract] [Full Text] [Related]
3. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS. Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319 [Abstract] [Full Text] [Related]
4. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H, Yoshida T, Horinaka M, Yasuda T, Goda AE, Konishi M, Wakada M, Kataoka K, Yoshikawa T, Sakai T. Cancer Res; 2008 Nov 01; 68(21):8918-27. PubMed ID: 18974136 [Abstract] [Full Text] [Related]
5. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF, Allen J, Hersey P, Zhang XD. Cancer Res; 2008 Aug 15; 68(16):6708-17. PubMed ID: 18701495 [Abstract] [Full Text] [Related]
6. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 15; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
7. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK. Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688 [Abstract] [Full Text] [Related]
8. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Geserick P, Drewniok C, Hupe M, Haas TL, Diessenbacher P, Sprick MR, Schön MP, Henkler F, Gollnick H, Walczak H, Leverkus M. Oncogene; 2008 May 15; 27(22):3211-20. PubMed ID: 18084329 [Abstract] [Full Text] [Related]
9. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK. Carcinogenesis; 2006 Oct 15; 27(10):2008-17. PubMed ID: 16613838 [Abstract] [Full Text] [Related]
10. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY. Mol Pharmacol; 2007 Nov 15; 72(5):1269-79. PubMed ID: 17684158 [Abstract] [Full Text] [Related]
11. The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells. Tseng HY, Chen LH, Ye Y, Tay KH, Jiang CC, Guo ST, Jin L, Hersey P, Zhang XD. Carcinogenesis; 2012 Oct 15; 33(10):1871-81. PubMed ID: 22791814 [Abstract] [Full Text] [Related]
12. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells. Lim JH, Park JW, Choi KS, Park YB, Kwon TK. Carcinogenesis; 2009 May 15; 30(5):729-36. PubMed ID: 19037087 [Abstract] [Full Text] [Related]
13. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D. FEBS J; 2008 Apr 15; 275(8):1925-36. PubMed ID: 18341587 [Abstract] [Full Text] [Related]
14. Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines. Kouhara J, Yoshida T, Nakata S, Horinaka M, Wakada M, Ueda Y, Yamagishi H, Sakai T. Int J Oncol; 2007 Mar 15; 30(3):679-87. PubMed ID: 17273769 [Abstract] [Full Text] [Related]
16. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. Kurbanov BM, Fecker LF, Geilen CC, Sterry W, Eberle J. Oncogene; 2007 May 17; 26(23):3364-77. PubMed ID: 17160022 [Abstract] [Full Text] [Related]
19. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function. Li Y, Wang H, Wang Z, Makhija S, Buchsbaum D, LoBuglio A, Kimberly R, Zhou T. Cancer Res; 2006 Sep 01; 66(17):8520-8. PubMed ID: 16951164 [Abstract] [Full Text] [Related]
20. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, Hersey P. Cancer Res; 2007 Oct 15; 67(20):9750-61. PubMed ID: 17942905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]